Offering hope of a simpler remedy for Hepatitis C, an experimental drug combination cured 70 percent of patients with the chronic liver disease in early trials, US researchers said Tuesday. The phase II trial described in the Journal of the American Medical Association (JAMA) studied the effectiveness and safety of an experimental drug, sofosbuvir, taken with the licensed antiviral drug ribavirin. The drugs were administered orally, an improvement over ...Wednesday, 28 August 2013
Experimental Drug Combo Cures Hepatitis C in Small Trials
Offering hope of a simpler remedy for Hepatitis C, an experimental drug combination cured 70 percent of patients with the chronic liver disease in early trials, US researchers said Tuesday. The phase II trial described in the Journal of the American Medical Association (JAMA) studied the effectiveness and safety of an experimental drug, sofosbuvir, taken with the licensed antiviral drug ribavirin. The drugs were administered orally, an improvement over ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment